Which scenario best illustrates appropriate use of patient consent in health information sharing for research?

• A. Sharing PHI for a defined research purpose only with patient consent
• B. Sharing PHI for any purpose without consent
• C. Using only de-identified data and ignoring consent
• D. Using PHI for marketing without consent

Answer: (A)

The main idea is that patient consent is the cornerstone for sharing identifiable health information used in research, ensuring patients control how their data is used and disclosed. Sharing PHI only for a defined research purpose after obtaining patient consent demonstrates respect for autonomy and privacy, and it helps limit data use to what the patient has agreed to while reinforcing trust and compliance with ethical and legal standards. This approach contrasts with scenarios where data is shared without consent, used for purposes outside the defined research scope, or used for marketing, all of which undermine patient privacy and the integrity of the research process. Understanding that de-identified data can sometimes be used without consent under specific rules helps clarify that the consent-focused scenario is about protecting identifiable information and ensuring clear, permitted use.